DISCUSSION
glucose intolerance, reductions in fasting plasma
GLUCOSE INTOLERANCE
The findings of this trial indicated a significantly positive effect of using pyridoxine as an additional therapy with Metformin on blood glucose levels and other factors examined in the research. Statistically significant reductions in fasting plasma glucose and HbA1c were seen in groups G2 and G3 during a 4-week treatment period compared to the patients in the control group (G1). Significant reductions in fasting serum insulin and HOMA-IR levels were found in groups G2 and G3 (p<0.05). Research has demonstrated that the inadequacy of vitamin B6 significantly impacts the development of glucose intolerance [